TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial.

Tim Flaadt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.